SCHEDULE: Gagnon Entities Adjust CareDx Stake

Gagnon Securities LLC, Gagnon Advisors, LLC, and Neil Gagnon have updated their beneficial ownership filings for CareDx, Inc., reporting a combined stake.

Summary

• Gagnon Securities LLC now beneficially owns 1,629,867 shares of CareDx, Inc. common stock, representing 3.2% of the class.
• Gagnon Advisors, LLC beneficially owns 408,837 shares, representing 0.8% of the class.
• Neil Gagnon personally beneficially owns 2,293,464 shares, representing 4.4% of the class.
• These filings reflect shared voting and dispositive power among the reporting persons and various accounts and funds managed by them.
• The reporting persons disclaim beneficial ownership of securities held in managed accounts beyond their stated interests.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports changes in beneficial ownership without disclosing new strategic information or financial performance.

Positives

• The reporting persons maintain a significant collective stake in CareDx, Inc., indicating continued investor interest.
• Clear disclosure of ownership percentages and share counts provides transparency to the market.

Negatives

• No new financial performance data or strategic initiatives are disclosed in this filing.
• The filing does not provide insight into the rationale behind any potential adjustments in holdings.

Risks

• Changes in beneficial ownership, even if not explicitly stated as sales or purchases, can sometimes precede or signal shifts in investor sentiment or strategy.
• The reliance on shared voting and dispositive power across multiple entities and accounts introduces complexity in understanding ultimate control and decision-making.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Management Comments

• Mr. Gagnon is the Chief Executive Officer and principal owner of Gagnon Securities LLC.
• Mr. Gagnon is the managing member of Gagnon Advisors, LLC.
• The reporting persons expressly disclaim beneficial ownership of all securities held in the Accounts and by GIA, except to the extent described herein.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors and significant shareholders, indicating changes in holdings or confirmation of existing positions. This filing pertains to the biotechnology sector, specifically companies involved in diagnostics.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant ownership stakes.
• Management: May face scrutiny or engagement from large, disclosed shareholders.
• Regulators: Compliance with SEC reporting requirements is maintained.

Key Dates

Keywords

CareDx, Gagnon Securities, Gagnon Advisors, Beneficial Ownership, Schedule 13G, Investment Adviser, Common Stock, SEC Filing